Loading...
SAT-621 An Atypical Case of Nivolumab-Induced Thyroiditis with Persistently Elevated Thyroid-Stimulating Immunoglobulin
BACKGROUND: The anti-PD1 monoclonal antibody nivolumab, approved for treatment of several cancers, is associated with ~ 3% rate of hyperthyroidism. Most cases are due to destructive thyroiditis. Stimulating antibodies against the TSH receptor (TSH-R) have not been reported in nivolumab-associated th...
Na minha lista:
| Udgivet i: | J Endocr Soc |
|---|---|
| Hovedforfatter: | |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Endocrine Society
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6552309/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/js.2019-SAT-621 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|